Figure 1c.
Dynamic contrast enhanced Breast MRI following 6 cycles Docetaxol shows no residual abnormal enhancement and complete resolution of the previous highly suspicious, typically malignant MR findings.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.